8OHR | pdb_00008ohr

Crystal structure of human heparanase in complex with glucuronic acid configured 3-geminal diol iminosugar inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 
    0.216 (Depositor), 0.227 (DCC) 
  • R-Value Work: 
    0.180 (Depositor), 0.193 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8OHR

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Molecular Basis for Inhibition of Heparanases and beta-Glucuronidases by Siastatin B.

Chen, Y.van den Nieuwendijk, A.M.C.H.Wu, L.Moran, E.Skoulikopoulou, F.van Riet, V.Overkleeft, H.S.Davies, G.J.Armstrong, Z.

(2024) J Am Chem Soc 146: 125-133

  • DOI: https://doi.org/10.1021/jacs.3c04162
  • Primary Citation Related Structures: 
    8CQI, 8OGX, 8OHQ, 8OHR, 8OHT, 8OHU, 8OHV, 8OHW, 8OHX

  • PubMed Abstract: 

    Siastatin B is a potent and effective iminosugar inhibitor of three diverse glycosidase classes, namely, sialidases, β- d -glucuronidases, and N -acetyl-glucosaminidases. The mode of inhibition of glucuronidases, in contrast to sialidases, has long been enigmatic as siastatin B appears too bulky and incorrectly substituted to be accommodated within a β- d -glucuronidase active site pocket. Herein, we show through crystallographic analysis of protein-inhibitor complexes that siastatin B generates both a hemiaminal and a 3-geminal diol iminosugar (3-GDI) that are, rather than the parent compound, directly responsible for enzyme inhibition. The hemiaminal product is the first observation of a natural product that belongs to the noeuromycin class of inhibitors. Additionally, the 3-GDI represents a new and potent class of the iminosugar glycosidase inhibitor. To substantiate our findings, we synthesized both the gluco - and galacto -configured 3-GDIs and characterized their binding both structurally and kinetically to exo-β- d -glucuronidases and the anticancer target human heparanase. This revealed submicromolar inhibition of exo-β- d -glucuronidases and an unprecedented binding mode by this new class of inhibitor. Our results reveal the mechanism by which siastatin B acts as a broad-spectrum glycosidase inhibitor, identify a new class of glycosidase inhibitor, and suggest new functionalities that can be incorporated into future generations of glycosidase inhibitors.


  • Organizational Affiliation
    • Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2300 RA Leiden, The Netherlands.

Macromolecule Content 

  • Total Structure Weight: 52.23 kDa 
  • Atom Count: 3,864 
  • Modeled Residue Count: 457 
  • Deposited Residue Count: 459 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Heparanase 50 kDa subunitA [auth AAA]385Homo sapiensMutation(s): 1 
Gene Names: HPSEHEPHPAHPA1HPR1HPSE1HSE1
EC: 3.2.1.166
UniProt & NIH Common Fund Data Resources
Find proteins for Q9Y251 (Homo sapiens)
Explore Q9Y251 
Go to UniProtKB:  Q9Y251
PHAROS:  Q9Y251
GTEx:  ENSG00000173083 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9Y251
Glycosylation
Glycosylation Sites: 1Go to GlyGen: Q9Y251-1
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Heparanase 8 kDa subunitB [auth BBB]74Homo sapiensMutation(s): 0 
Gene Names: HPSEHEPHPAHPA1HPR1HPSE1HSE1
EC: 3.2.1.166
UniProt & NIH Common Fund Data Resources
Find proteins for Q9Y251 (Homo sapiens)
Explore Q9Y251 
Go to UniProtKB:  Q9Y251
PHAROS:  Q9Y251
GTEx:  ENSG00000173083 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9Y251
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG

Query on NAG



Download:Ideal Coordinates CCD File
F [auth AAA]2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
VP5
(Subject of Investigation/LOI)

Query on VP5



Download:Ideal Coordinates CCD File
C [auth AAA](3~{S},4~{R})-4,5,5-tris(oxidanyl)piperidine-3-carboxylic acid
C6 H11 N O5
VJJFPBNJYGLWRR-IUYQGCFVSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
D [auth AAA],
E [auth AAA],
G [auth AAA]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
H [auth AAA]CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free:  0.216 (Depositor), 0.227 (DCC) 
  • R-Value Work:  0.180 (Depositor), 0.193 (DCC) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 44.436α = 90
b = 71.08β = 98.433
c = 78.232γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
DIALSdata reduction
DIALSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Netherlands Organisation for Scientific Research (NWO)NetherlandsVI.Veni.212.173
European Research Council (ERC)European UnionERC-2011-AdG-290836
European Research Council (ERC)European UnionERC-2012-AdG-32294
European Research Council (ERC)European UnionERC-2020-SyG-951231
Biotechnology and Biological Sciences Research Council (BBSRC)United KingdomBB/R001162/1
Biotechnology and Biological Sciences Research Council (BBSRC)United KingdomBB/M011151/1

Revision History  (Full details and data files)

  • Version 1.0: 2024-01-10
    Type: Initial release
  • Version 1.1: 2024-01-24
    Changes: Database references
  • Version 1.2: 2024-10-09
    Changes: Structure summary